Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion type Assertion NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_head.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion description "[This study suggests that XPD rs1799793 could be a marker of osteosarcoma associated with features conferring either a better prognosis or a better outcome after platinum therapy, or both.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_provenance.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion evidence source_evidence_literature NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_provenance.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion SIO_000772 21826087 NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_provenance.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion wasDerivedFrom befree-2016 NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_provenance.
- NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_assertion wasGeneratedBy ECO_0000203 NP915579.RAucQKYtpxRup-l9qUxahMG9u22ZtQ3X-WKyj8R7iwUNY130_provenance.